What MicroMedMark does

The legal entity 江苏命码生物科技有限公司 (Jiangsu Mingma Biotechnology Co., Ltd., operating as MicroMedMark) presents a significant identity mismatch between its registered name — which implies a biotechnology orientation (命码 loosely translates to "life code") — and the actual observable business conducted through its website, micromedmark.com. The website functions as a generic enterprise information portal, organized around four template-style service modules: 企业查询 (Enterprise Query), which aggregates third-party lookups against China's National Enterprise Credit Information Publicity System, MIIT ICP filing system, and commercial credit platforms such as Qichacha and Tianyancha; 企业推广 (Enterprise Promotion), which provides generic marketing guidance covering SEO, paid advertising, social media, email, and content marketing; 企业招聘 (Enterprise Recruitment), which offers recruitment best-practice content including a brief generic reference to AI-assisted candidate screening; and 企业服务 (Enterprise Services), a broad directory spanning IT, finance, logistics, marketing, translation, intellectual property, design, printing, security, accommodation, health, and education services.

The platform's content is template-generated and largely boilerplate; multiple pages reference "仁怀企业网" (Renhuai Enterprise Network), suggesting the site was produced from a regional template and deployed under the MicroMedMark domain. There is no evidence on the website of proprietary biomedical technology, in-vitro diagnostic reagents, drug development services, regulatory filings (e.g., NMPA medical device registrations), scientific publications, or specialized life-sciences offerings that would align with the "biomedical company specialized in vitro diagnostic reagents and drug development services" descriptor in the firm's short description. The site footer indicates maintenance through 2023, and the company is headquartered in Nanjing, Jiangsu Province, with 11–50 employees and a single disclosed funding event.

The revenue model is not publicly disclosed: no pricing, no named customer logos, no contract vehicles, no subscription tiers, and no transaction data are described. The only funding on record is a $433,601 round on 2016-11-25 from Yinxinggu Capital. Ownership, management team, board composition, and any biomedical operating subsidiary or R&D facility are not disclosed in the available materials. The enterprise portal appears to be a low-overhead regional information site rather than a monetizable biomedical product business, and the gap between the legal naming, the short description, and the actual web presence represents a material diligence flag.

Name

MicroMedMark

Legal name

江苏命码生物科技有限公司

Website

https://micromedmark.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

MicroMedMark (江苏命码生物科技有限公司) operates a generic enterprise information portal from Nanjing, Jiangsu, offering four template-based service modules: enterprise query, marketing guidance, recruitment advisory, and a multi-category business services directory. Despite its biotech-oriented legal name, no biomedical or IVD activity is observable on its website.

Ownership category

akta.pro rank

Product category

Enterprise Business Information Services

NAICS

Web Search Portals and All Other Information Services (519290)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Enterprise information services
• Business directory platform
• Corporate marketing services
• Recruitment advertising services
• B2B service portal

Headquarters

HQ city

Nanjing

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Core offering

MicroMedMark operates an online enterprise information portal that provides four core service modules: enterprise information lookup (company registration, administrative licenses, penalties via national credit and MIIT systems), enterprise promotion (marketing strategy, SEO, social media, paid ads), enterprise recruitment (job posting, candidate screening, AI-assisted hiring), and a multi-category enterprise services platform spanning IT, finance, logistics, marketing, translation, intellectual property, design, printing, security, accommodation, health, and education services.

Product overview

MicroMedMark operates as a comprehensive enterprise business information portal providing four core service modules: Enterprise Query (企业查询) for company information verification, Enterprise Promotion (企业推广) for marketing and brand building, Enterprise Recruitment (企业招聘) for talent acquisition with AI-powered efficiency tools, and Enterprise Services (企业服务) as a multi-category service aggregation platform offering IT services, financial services, logistics, marketing, translation, intellectual property, design, printing, security, accommodation, health, and education services. The platform functions as a regional enterprise information network for Jiangsu Province, combining enterprise information lookup, brand display, and product promotion services.

Differentiator

Problem solved

Functional benefit

Products and services

• Enterprise Query (企业查询)

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights2 records

Broad incumbents

• BGI Genomics: Shenzhen-based genomics and molecular diagnostics leader offering a broad IVD/reagent portfolio across clinical and research markets. Comparable to MicroMedMark's stated IVD and biotech focus, though operating at vastly greater scale and breadth.
• KingMed Diagnostics: One of China's largest third-party medical laboratory/diagnostics service providers with a national footprint. Relevant peer given the company description's positioning around diagnostic reagents/services, though KingMed operates independent clinical labs rather than reagent manufacturing.
• Mindray (Shenzhen Mindray Bio-Medical): Largest Chinese medical-device and IVD company, with substantial in-vitro diagnostic reagent and analyzer portfolio. Comparable in vertical but incomparable in scale; included to anchor the upper bound of the Chinese IVD market context.
• Qcc.com (企查查): Major Chinese enterprise-information lookup and business-data platform. Included as a peer to the portal/query functionality actually evidenced by MicroMedMark's live website, rather than its stated biotech business.

Direct peers

• Da An Gene (Daan Diagnostics): Guangzhou-based molecular diagnostics and IVD reagent company focused on clinical nucleic-acid testing kits and platforms. Closest functional peer to a small Chinese IVD-reagent developer positioning in clinical diagnostics.
• Autobio Diagnostics: Chinese in-vitro diagnostics company that develops, manufactures, and markets a broad IVD reagent menu (chemiluminescence, microbiology, etc.) for clinical labs. Directly comparable to MicroMedMark's stated IVD-reagent profile.
• Lepu Diagnostics: Beijing-based subsidiary of Lepu Medical focused on IVD reagents, immunoassays, and POCT devices for the Chinese clinical market. Direct comparable as a Chinese mid-sized IVD-reagent manufacturer serving hospital labs.
• Innovita Biological Technology: Chinese IVD manufacturer focused on respiratory, infectious disease, and women's health diagnostic kits/reagents. Closely comparable to the stated IVD-reagent, drug-development-adjacent positioning of MicroMedMark at similar scale band.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks6 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MicroMedMark